An Update on Machine Learning in Neuro-oncology Diagnostics
원문 초록
Imaging biomarkers in neuro-oncology are used for diagnosis, prognosis and treatment response monitoring. Magnetic resonance imaging is typically used throughout the patient pathway because routine structural imaging provides detailed anatomical and pathological information and advanced techniques provide additional physiological detail. Following image feature extraction, machine learning allows accurate classification in a variety of scenarios. Machine learning also enables image feature extraction de novo although the low prevalence of brain tumours makes such approaches challenging. Much research is applied to determining molecular profiles, histological tumour grade and prognosis at the time that patients first present with a brain tumour. Following treatment, differentiating a treatment response from a post-treatment related effect is clinically important and also an area of study. Most of the evidence is low level having been obtained retrospectively and in single centres.
함께 살펴볼 논문
공통 태그를 근거로 연결했습니다. 실제 인용 관계나 논문의 우수성을 뜻하지 않습니다.
CrossFusion: A Multi-Scale Cross-Attention Convolutional Fusion Model for Cancer Survival Prediction
Learning Disentangled Stain and Structural Representations for Semi-Supervised Histopathology Segmentation
MiCo: Multiple Instance Learning with Context-Aware Clustering for Whole Slide Image Analysis
Revisiting End-to-End Learning with Slide-level Supervision in Computational Pathology
Cardiac Digital Twins at Scale from MRI: Open Tools and Representative Models from ~55000 UK Biobank Participants
Zero-Shot Multi-modal Large Language Model v.s. Supervised Deep Learning: A Comparative Study on CT-Based Intracranial Hemorrhage Subtyping
토론
이 논문과 연결된 포럼 글이 아직 없습니다.